Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study (Q46807374)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study |
scientific article |
Statements
1 reference
Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study (English)
1 reference
Itamar Raz
1 reference
Stephen Stranks
1 reference
Robert Filipczak
1 reference
Pankaj Joshi
1 reference
Benedikte Lertoft
1 reference
Jacob Rastam
1 reference
Chun-Chung Chow
1 reference
Joseph Shaban
1 reference
1 September 2005
1 reference
1 reference
27
1 reference
9
1 reference
1432-1443
1 reference
Identifiers
1 reference
1 reference